Vanderbilt Vaccine Research Program

Bird flu vaccine more effective with potent adjuvant

The avian (bird) influenza vaccine creates a more robust immune response when paired with a potent ingredient known as an adjuvant, according to Vanderbilt research published in The Journal of Infectious Diseases.

Study finds Moderna’s COVID-19 vaccine safe and effective for young children

A Vanderbilt study finds that Moderna’s COVID-19 vaccine is safe and effective in children 6 months to 5 years of age.

VUMC study will evaluate alternative strategies for administering monkeypox vaccine

Vanderbilt is seeking about 30 healthy adults of diverse backgrounds to participate in a national clinical trial to evaluate alternative strategies for administering the monkeypox vaccine

Study to evaluate nasal flu vaccine for children

Pediatricians with the Vanderbilt Vaccine Research Program are looking for healthy infants and children (6 months – 8 years of age) to take part in a nasal influenza vaccine study.

VUMC-led study finds Moderna COVID vaccine safe and effective for children

Amya Elliott, 9, talks with Bonnie Pilon, RN, prior to receiving her COVID-19 vaccination at Monroe Carell Jr. Children’s Hospital at Vanderbilt. The hospital began mass vaccination for children ages 5-11 on Monday, Nov. 8.

MIS-C diagnosis rare in vaccinated children with no previous COVID-19 diagnosis

A Vanderbiltl study found that children who received the COVID-19 vaccine who had not previously been diagnosed with COVID infection are unlikely to be diagnosed with multisystem inflammatory syndrome in children (MIS-C).

1 2 3